Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance

Therapies targeting signaling molecules mutated in cancers can often have striking short-term effects, but the emergence of resistant cancer cells is a major barrier to full cures(1,2). Resistance can result from a secondary mutations(3,4), but other times there is no clear genetic cause, raising th...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaffer, Sydney M., Dunagin, Margaret C., Torborg, Stefan R., Torre, Eduardo A., Emert, Benjamin, Krepler, Clemens, Beqiri, Marilda, Sproesser, Katrin, Brafford, Patricia A., Xiao, Min, Eggan, Elliott, Anastopoulos, Ioannis N., Vargas-Garcia, Cesar A., Singh, Abhyudai, Nathanson, Katherine L., Herlyn, Meenhard, Raj, Arjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542814/
https://www.ncbi.nlm.nih.gov/pubmed/28607484
http://dx.doi.org/10.1038/nature22794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542814/
https://www.ncbi.nlm.nih.gov/pubmed/28607484
http://dx.doi.org/10.1038/nature22794

Ejemplares similares